The parent company, The Boots Company Plc, merged with Alliance UniChem in 2006 to form Alliance Boots. In 2007, Alliance Boots was bought by Kohlberg Kravis Roberts and Stefano Pessina, taking the company private, and moving its headquarters to Switzerland, making it the first ever FTSE 100 company to be bought by a private equity firm. In 2012, Walgreens bought a 45% stake in Alliance Boots, with the option to buy the rest within three years. It exercised this option in 2014, and as a result Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.
Boots is one of the largest retailers in the UK and Ireland, both in terms of revenue and the number of shops. They have 2,500 shops across the United Kingdom and Ireland ranging from local pharmacies to large health and beauty shops. Their shops are primarily located on the high streets and in shopping centres. It sells many health and beauty products, and also provides optician and hearing care services within shops and as standalone practices. Boots also operates a retail website and since 1997 it runs a loyalty card programme called the Boots Advantage Card.
|Boots UK Ltd|
|Boots the Chemists|
Boots Cash Chemists
|Founded||1849, Nottingham, United Kingdom|
|Headquarters||Beeston, Nottingham, United Kingdom|
|Sebastian James, President and Managing Director, Boots UK and ROI (since September 2018)|
|Brands||No7, natural collection and Soap and Glory – Skincare|
Soltan – Sun cream
Number of employees
|Parent||Walgreens Boots Alliance|
|Subsidiaries||Boots Opticians |
Boots Retail Ireland
Boots was established in 1849, by John Boot. After his father's death in 1860, Jesse Boot, aged 10, helped his mother run the family's herbal medicine shop in Nottingham, which was incorporated as Boot and Co. Ltd in 1883, becoming Boots Pure Drug Company Ltd in 1888. In 1920, Jesse Boot sold the company to the American United Drug Company. However, because of deteriorating economic circumstances in North America Boots was sold back into British hands in 1933. The grandson of the founder, John Boot, who inherited the title Baron Trent from his father, headed the company. The Boots Pure Drug Company name was changed to The Boots Company Limited in 1871.
Between 1898 and 1966, many branches of Boots incorporated a lending library department, known as Boots Book-Lovers' Library.
Boots diversified into the research and manufacturing of drugs with its development of the Ibuprofen painkiller during the 1960s, invented by John Nicholson and Stewart Adams. The company was awarded the Queen's Award For Technical Achievement for this in 1987. A major research focus of Boots in the 1980s was the drug for congestive heart failure Manoplax. The withdrawal from market of Manoplax due to safety concerns in 1993 caused major pressure from investors, and in 1994, Boots divested its prescription drugs division, which had become no longer viable, to BASF. In 2006, it sold the Nurofen brand to Reckitt Benckiser. The 2006 sale of Boots Healthcare International included everything made by Crookes Healthcare, based on the Nottingham site.
In 1968 Boots acquired the 622-strong Timothy Whites and Taylors Ltd chain. Boots expanded into Canada by purchasing the Tamblyn Drugs chain circa 1978. Most Canadian Boots shops were converted to Pharma Plus in 1989, although a handful of locations remained as late as 1993, if not later. In 1982, the company opened a new manufacturing plant in Cramlington, Northumberland. In the early 1990s, Boots began to diversify and bought Halfords, the bicycle and car parts business in 1991. It also developed the Children's World business but sold it in 1996 to Mothercare. Halfords was sold in 2002.
Boots Opticians Ltd was formed in 1987 with the acquisition of Clement Clarke Ltd and Curry and Paxton Ltd. Boots Opticians became the UK's second largest retail optics chain. In 2009 Boots Opticians acquired Dollond & Aitchison, an optician chain which was founded in 1750.
Boots diversified into dentistry in 1998, with a number of shops offering this service. Boots sold its Do-It-All home furnishings chain to Focus in 1998. Boots also made a venture into "Wellbeing" services offering customers treatments ranging from facials, homoeopathy, and nutritional advice to laser eye surgery and Botox but these services were abandoned in 2003, despite a launch that included a dedicated Freeview and Sky TV channel of the same name, and even redirecting web traffic from boots.com to wellbeing.com
In October 2005, a merger with Alliance UniChem was announced by the then chairman, Sir Nigel Rudd. The CEO Richard Baker left, and the new group became Alliance Boots plc. The merger became effective on 31 July 2006.
Alliance Boots was purchased by Kohlberg Kravis Roberts and Stefano Pessina, the deputy chairman of the company, in April 2007 for £11.1 billion, taking the company private and beating a rival bid from Guy Hands' Terra Firma Capital Partners. This was the first ever instance of a FTSE 100 company having been bought by a private equity firm. In June 2008, the group headquarters were moved to Zug, Switzerland. According to John Ralfe, Boots' former head of corporate finance, "the UK has lost about £100m a year in tax as result".
On 19 June 2012, it was announced that Walgreens, the United States' largest chemist chain, would purchase a 45% stake in Alliance Boots for US$6.7 billion. The deal was said to be a long term plan to give maximum exposure to both brands, Boots more so in the US and, Walgreens more so in the UK and in China through Boots' presence in that market. The deal gave the option to complete a full merger of the organisations within three years costing an extra $9.5bn. Walgreens confirmed on 6 August 2014 that it would purchase the remaining 55% and merge with Alliance Boots to form a new holding company, Walgreens Boots Alliance Inc. Walgreens and Boots both become subsidiaries of the new company on 31 December 2014.
On 2 April 2019, Boots announced it would sponsor the England, Scotland, Wales, Northern Ireland and Republic of Ireland women's football teams in a multi-million pound/euro deal. The deal will last three years and cover the 2019 FIFA Women's World Cup and the UEFA Women's Euro 2021 competitions.
On 28 May 2019, Boots announced that it was considering the closure of 200+ underperforming shops.
Boots sell the following products and services:
In 2009 Boots Superintendent Pharmacist Paul Bennett was interviewed by the House of Commons Science and Technology Committee about the company’s sale of homeopathic medicines. He told the committee that the company had no evidence to suggest that homeopathic medicines are efficacious but Boots sold them anyway, for reasons of “consumer choice”. The comments attracted significant media attention. 
In April 2016, the Pharmacists' Defence Association stated that company managers were exploiting the NHS by insisting that each outlet carry out medicine use reviews, even if patients didn’t need them. The NHS pays £28 per review up to a maximum of 400 per shop per year. The Guardian said that the General Pharmaceutical Council was poised to investigate.
At the same time as the article about medicines reviews, The Guardian published a longer report on the same day called 'How Boots went Rogue', which told the story from the eyes of a Boots pharmacist talking about working conditions at the company. It also covered the buyout of the company and the owners' financial approach. Four days later it published an articles with emails from pharmacists. Pharmacists had written about how "the chain allegedly compels staff to compromise ethics for targets". The article said "The letters editor believes this may be the largest haul of mail he has ever received about a single article. Others rang in." There were two further follow-up articles in the days following. The paper subsequently noted a letter purporting to be from an "independent pharmacist" criticising its stance on the issue which it identified as having been edited and amended by one of the firm's vice-presidents. The letter was emailed as a Word document and contained tracked changes.
On 8 January 2018, the BBC showed a documentary called "Boots: Pharmacists under Pressure?" about the deaths of three patients following dispensing errors. It also featured accounts from three whistleblowers, who alleged that there were staffing issues at the company. One of the whistleblowers, who had formerly worked in a patient safety role, stated that Boots had calculated that in excess of £100m additional investment in staffing was required each year in its pharmacies and to meet the company's expectations of its staff. The BBC also published two articles on the same day.
A separate article almost three weeks later told the story of a patient who was given the wrong medicine in December 2017 by a "frazzled" pharmacist. The patient said there was clearly a staffing issue.
Boots had told the BBC documentary makers that there had been no further patient deaths associated with dispensing errors since 2015. However, in July 2018, it was reported that an error had occurred in 2016 in which two lots of the same medicines were dispensed and supplied to the same patient, Richard Lee, who subsequently died. The error was found at a coroner’s inquest to have contributed to his death.
In July 2017, the British Pregnancy Advisory Service (BPAS) revealed that Boots was selling emergency contraceptive medication at four times the cost price and had refused requests to join rival pharmacy retail chains, including Superdrug and Tesco, which had agreed to cease profiting financially in this way. In a written response to BPAS, Boots revealed that they were frequently contacted by individuals who disapproved of the dispensing of such medication, which might be viewed as "incentivising inappropriate use", an assertion which campaigners described as "insulting and sexist". BPAS called on the public to boycott the company and email them requesting that they reverse the policy. Following the boycott's launch, lawyers representing Boots alleged that the online complaint form created by BPAS had resulted in a "torrent of abuse" to five of Boots' senior managers and that BPAS had facilitated and tacitly encouraged harassment by naming individual staff members on the form. In response, BPAS stated that Boots had "failed to provide any evidence of abuse sent through the campaign". In November 2017, more than 130 Labour politicians signed a letter criticising Boots' failure to fulfil its promise to stock a low-cost alternative in its shops by October. At the end of January 2018, Boots confirmed that it was now offering the cheaper medication in all of its pharmacies.
Throughout the media coverage, a May–July 2017 pricelist from its wholesaler and sister company Alliance Healthcare stated that the "Normal Retail Price inc. VAT" of Levonelle One Step was £12.72. Levonelle One Step was the morning after pill which was the subject of the media attention, and which Boots was selling for £28.25. This does not appear to have been picked up on by the press.
On 25 October 2017, a debate was held in the House of Commons about pharmacists' mental health and the support that employers give to employees. Much of the discussion concerned the suicide of a Boots pharmacist, Alison Stamps, in May 2015, and Boots' response was criticised. Part of a letter from Alison Stamps’ parents was read out by MP Kevan Jones, which said: “It is clear that Alison was a victim of corporate greed and collateral damage by an uncaring company intent only on its own agenda.”
In February 2018, Boots was criticised for charging excessive prices for low-value products supplied to the NHS: in one case, it was found that the pharmacy was billing in excess of £1,500 for a moisturiser which normally retailed at less than £2. In May 2018, a further investigation by The Times found that on at least five occasions between 2013 and 2017, Boots had charged over £3,200 for a medicinal mouthwash used to treat mouth ulcers in chemotherapy patients, in comparison to an independent supplier which had charged the equivalent of £93 for the same product. The investigation found that Boots had ordered the product from Alliance Healthcare, a supplier owned by Boots' parent company. In response, a spokesman for Walgreens Boots Alliance rejected accusations of overcharging the NHS and claimed that the bespoke nature of the orders, often requested at short notice, results in the high cost.
The company funds the Boots Charitable Trust, which is an independent registered charity in the UK, administrated by Nottinghamshire Community Foundation. The trust was established in the early 1970s to fund registered charities benefiting people who live in Nottinghamshire.
Supporting BBC Children in Need 
Supporting Macmillan Cancer Support 
Supporting "WE Feel Good" 
Supporting The Prince’s Trust
The Boots Benevolent Fund
The Boots Estate, near the Nottingham suburb of Beeston, features a range of listed buildings. This includes the two principal factory buildings, D6 and D10, designed by Sir Owen Williams and built in 1932 and 1935–38 respectively. Both are Grade I listed. The former fire station, D34, is also by Williams and is Grade II listed. The headquarters office building known as D90 is Grade II* and was built to designs by Skidmore, Owings & Merrill in 1966–68. Staff have a restaurant, coffee and snack shops, newsagent, a branch of Boots the Chemist, an opticians branch and cash point situated within landscaped grounds. The grounds include the Millennium Garden, which features a herb garden (with some plants that Jesse used in his original herbal remedies) in the shape of a goose foot – harking back to Jesse's original shop on Goose Gate, Nottingham.
The Boots Museum is now closed; however, historical items are in storage or on display in the reception area of the D90 building.
Alliance Boots GmbH was a multinational pharmacy-led health and beauty group with corporate headquarters in Bern, Switzerland and operational headquarters in Nottingham and Weybridge, United Kingdom.
The company had a presence in over 27 countries including associates and joint ventures and in 2013/14, reported revenue in excess of £23.4 billion. It had two core business activities – pharmacy-led health and beauty retailing, and pharmaceutical wholesaling and distribution – and also increasingly developed and internationalised its product brands.
The company was formed in 2006 by the merger of the British high street pharmacist Boots Group and the pan-European wholesale and retail pharmacy group Alliance UniChem and was listed on the London Stock Exchange as Alliance Boots plc. In 2007 it was bought out in a private equity transaction by AB Acquisitions Limited, led by Stefano Pessina and Kohlberg Kravis Roberts (KKR). Alliance Boots GmbH was established in Switzerland during 2008 and is a direct subsidiary of AB Acquisitions Holdings Limited, which held all shares in the company. In August 2012, the US company Walgreens purchased 45% of shares as part of a plan to merge the two businesses, with an option to acquire the remaining shares within three years. It exercised that option in August 2014, and following shareholder and regulatory approvals, the two businesses merged on 31 December 2014 to form Walgreens Boots Alliance.The group's operations were mainly carried out under the Boots and Alliance Healthcare brands. Boots UK is the UK's leading pharmacy-led health and beauty retailer. Alliance Boots is also the largest pharmaceutical wholesaler in the UK through its Alliance Healthcare (Distribution) Ltd business. The company employs over 120,000 staff and operates more than 4,600 retail stores, of which just over 4,450 have pharmacies. Alliance Boots pharmaceutical wholesale division serves over 180,000 pharmacies, doctors, hospitals and health centres from over 370 distribution centres in 20 countries. Both companies became subsidiaries of Walgreens Boots Alliance on completion of the merger.Blotting paper
Blotting paper, sometimes called bibulous paper, is a highly absorbent type of paper or other material. It is used to absorb an excess of liquid substances (such as ink or oil) from the surface of writing paper or objects. Blotting paper referred to as bibulous paper is mainly used in microscopy to remove excess liquids from the slide before viewing. Blotting paper has also been sold as a cosmetic to aid in the removal of skin oils and makeup.Boots Opticians
Boots Opticians Ltd. operates a chain of ophthalmic and dispensing optician stores in the United Kingdom. The company is a subsidiary of Walgreens Boots Alliance (58%) and De Rigo (42%).Company Chemists’ Association
The Company Chemists’ Association was established in 1898. It aims to influence policy and support market development for its members, all large businesses.It now has 8 members: Asda, Boots UK, Lloydspharmacy, Wm Morrison Supermarkets, Rowlands Pharmacy, Superdrug, Tesco and Well Pharmacy. Together they own over 6,500 pharmacies - almost 50% of the pharmacies in the United Kingdom.It speaks for its members in relation to government proposals which impact on pharmacies.It was involved in the joint project, Pharmacy Voice, with the National Pharmacy Association and the Association of Independent Multiple Pharmacies. It was closed in April 2017.Malcolm Harrison, a former senior manager at Boots UK, was appointed chief executive in March 2018.Elizabeth Fagan
Elizabeth Fagan (born August 1957) is a Scottish businesswoman, and the managing director of Boots UK.Flosequinan
Flosequinan is a quinolone vasodilator that was discovered and developed by Boots UK and was sold for about a year under the trade name Manoplax. It had been approved in 1992 in the US and UK to treat people with heart failure who could not tolerate ACE inhibitors or digitalis.Boots initiated a clinical trial called PROFILE to see if the drug could be useful in a wider population. The study was terminated early in 1993 due to increased mortality in the drug arm of the trial; preliminary results were published in a conference abstract by the PI Milton Packer and others, which promised data and analysis would be forthcoming in a future paper, which was finally published in 2017.
Boots withdrew it from the market in July 1993.Flurbiprofen
Flurbiprofen is a member of the phenylalkanoic acid derivative family of nonsteroidal anti-inflammatory drugs (NSAIDs). It is primarily indicated as a pre-operative anti-miotic (in an ophthalmic solution) as well as orally for arthritis or dental pain. Side effects are analogous to those of ibuprofen.It was derived from propionic acid by the research arm of Boots UK during the 1960s, a period which also included the discovery of ibuprofen, indometacin, diclofenac, naproxen, ketoprofen, and sulindac.It was patented in 1964 by Boots UK and approved for medical use in 1987. It was approved in the US in 1988; the first generic was approved in 1994.John Boot
John Boot (1815 – 1860) was the founder of Boots the Chemists. His son Jesse Boot transformed the company into a retailer known throughout the world.
Boot was born in Radcliffe on Trent in 1815 and was a farm worker until illness forced him to change career. Boot moved to Hockley Village.
From the herbal remedies his mother made, Boot started up a trade of making and selling herbal remedies. Boot was not trained as a chemist and learned his later profession.
He later married Mary Wills who gave birth to two children: Jesse and Jane.
In 1849 Boot opened his herbalist shop in Goose Gate, Nottingham, that would become the roots of the Boots UK empire.
Even as a chemist, Boot's health did not improve and he died in 1860, leaving his wife and business behind. Mary Boot carried on with the business as M & J Boot, Herbalists.NG postcode area
The NG postcode area, also known as the Nottingham postcode area, is a group of postcode districts around Nottingham that covers central Nottinghamshire and parts of Derbyshire, Leicestershire and Lincolnshire.No. 7 (brand)
No7 is a brand of anti-ageing creams, skincare and cosmetic products developed by Boots UK.
The brand No. 7 was launched by Boots in 1935 as a selection of eleven skincare products and was expanded in 1937 with some colour cosmetics. Since its introduction, the brand has undergone eight redesigns. In 2007, Boots expanded the range to incorporate body products, foundation, creams and men's skincare.Sebastian James
Sebastian Richard Edward Cuthbert James (born 11 March 1966) is a British businessman, who was formerly CEO of Dixons Carphone , and is the current CEO of Boots UK.Simon Roberts
Simon Roberts may refer to:
Simon Roberts (actor), British actor
Simon Roberts (photographer) (born 1974), British socio-documentary photographer
Simon Roberts (Herefordshire cricketer) (born 1983), English cricketer, played for Herefordshire 2002–09
Simon Roberts (Cambridge cricketer) (born 1926), South African cricketer, played for Cambridgeshire and Cambridge University in the 1940s
Simon Roberts (footballer) (1876–?), Australian rules footballer
Simon Roberts (businessman), Managing Director of Boots UK & ROISimon Roberts (businessman)
Simon John Roberts (born 26 January 1971) is a British businessman and former managing director of Boots UK.Smalltown Boy
"Smalltown Boy" is a song by the British synth-pop group Bronski Beat. It was released in 1984 and appeared on the band's debut album The Age of Consent, released in December 1984.
The song is a popular gay anthem and was a big commercial success, reaching number 3 in the band's native UK. It was also a number one hit in the Netherlands and Belgium, and hit the top 10 in Australia, Canada, France, Ireland, Italy and Switzerland. The track reached number 48 in the US pop chart and was a number one US dance hit.
The song was released again in December 2013 after featuring in a Christmas advertising campaign for Boots UK. Smalltown Boy was also re-recorded by Jimmy Somerville and released as Smalltown Boy Reprise (2014) for the 30th anniversary of its initial release.Somethin' Else (content agency)
Somethin' Else is a London content agency founded in 1991 by Jez Nelson, Chris Philips and Sonita Alleyne. The company's first production was the Gilles Peterson Show, created for the UK's independent radio network in 1993. The agency specialises in content strategy and production across video, television, audio and social media. In 2017 it was the only company in the UK to feature in Campaign Magazine's School Reports and Broadcast Magazine's Top 100.
It is the BBC's biggest multi-platform supplier, currently producing over 35 weekly radio shows, television for BBC 4 and iPlayer and creating social media for the BBC's music radio brands.
Somethin' Else has won Cannes Lions, eight BAFTA awards and multiple Sony Radio Academy Awards. They were awarded Children's Company of the Year award in the 2013 and 2015 Children's BAFTAs. In 2016, the agency also won a Marketing Week award for 'Most Compelling Content' for their game Silverpoint for Absolut Vodka, and a Broadcast Digital Award for Best Social Media Campaign for its work on the BRIT Awards.
Past and present clients of Somethin' Else include the BBC, TOPMAN, The Economist, Channel 4, Sky Arts, Interflora, Swarovski, ITV, Penguin Random House, Red Bull, Boots UK, Porsche, Chivas Regal, FIAT, Nissan, Wrigley, Rolls-Royce and The British Phonographic Industry.Notable Somethin' Else productions include Kermode and Mayo's Film Review, Gardeners' Question Time, social media for The BRIT Awards and ITV and TV hits Guitar Star, The Ronnie Wood Show and Brian Johnson's A Life on the Road.Somethin' Else's board is Jez Nelson, Steve Ackerman (MD), Paul Burdin (FD) and Ben Kerr. The chairman is Tom Barnicoat (former COO at Endemol group) and Jon Wilkins (founder of Naked) and Lindsey Clay (CEO Thinkbox) are non-executive directors.Stephen Russell (cricketer)
Stephen George Russell (born 13 March 1945) is a former English first-class cricketer and businessman.
Russell attended Tiffin School before going up to Trinity Hall, Cambridge. Opening the bowling and showing "commendable control at a lively pace", he won his cricket Blue for Cambridge University in 1965 and took 4 for 50 and 4 for 32 against Oxford University.He had his best season in 1966, taking 41 wickets in 14 first-class matches for Cambridge at an average of 25.24. In Cambridge's sole victory that year, over Scotland, he took 3 for 49 and 5 for 41, including the first four wickets in Scotland's second innings, and then, coming in to bat at his usual position of number 11 with Cambridge needing 42 runs to win, he stayed with Rupert Roopnaraine while the runs were scored. He took 5 for 60 against Oxford, but Cambridge lost by an innings.He "proved an inspiring captain" for Cambridge in 1967, but was less successful as a bowler, taking 19 wickets in 11 matches at an average of 44.26. He played one match for Surrey at the end of the season, taking two wickets.He went into business, and was a director of Boots UK.Superdrug
Superdrug Stores plc (trading as Superdrug) is a health and beauty retailer in the United Kingdom, and the second largest behind Boots UK. The company has been a subsidiary of A.S. Watson Group since October 2002, itself part of the Hong Kong conglomerate CK Hutchison Holdings.
It trades from nearly 900 shops across the United Kingdom and Ireland and also serves Sweden, Finland and Norway online. Superdrug employs over 14,000 people, ranging from minimum-wage jobs to some of the highest-paid within the industry. As of 2016, Superdrug was the United Kingdom's fastest growing health and beauty retailer, more than doubling its profit in 2015.Besides health and beauty products, the company also has pharmacies with consultation rooms in over 220 shops, and a further 19 contain nurse clinics, making it the fourth largest chemist chain in the United Kingdom. It maintains links with sister companies also owned by A.S. Watson Group: Savers and The Perfume Shop.Well Pharmacy
Well, formerly The Co-operative Pharmacy, is the largest independent pharmacy business and the third largest overall pharmacy chain after Boots UK and Lloyds Pharmacy in the United Kingdom. It is the largest pharmacy chain in Wales.
Following months of speculation, The Co-operative Group revealed in July 2014, that they had come to an agreement to divest the pharmacy business to the Bestway Group for £620 million. The sale was completed in October 2014 and Bestway were given a licence to continue using the Co-operative brand for 12 months. In 2015, Bestway began to rebrand the company as Well.
Other retail co-operatives in the United Kingdom, such as Midcounties Co-operative, continue to operate Co-op Pharmacy branded stores, which were not affected by the sale.